Skip to main content
OpenTrials

Clinical trial condition

Refractory Acute Lymphoblastic Leukemia

Explore clinical trials studying Refractory Acute Lymphoblastic Leukemia. Study availability and eligibility vary by location and protocol.

39 public trials 14 recruiting studies
Refine in advanced search Browse all conditions

Refractory Acute Lymphoblastic Leukemia trial results

Recruiting

Autologous and Donor-derived CD7 CAR-T Therapy in Refractory or Relapsed T-cell Malignancies

NCT06316427

Conditions
Acute Lymphoblastic Leukemia, in Relapse, Hematologic Diseases, Hemic and Lymphatic Diseases, +13 more
Locations
  • Beijing GoBroad Hospital Beijing, Beijing Municipality, China
  • Zhaxin Hospital of Integrated Traditional Chinese and Western Medicine Shanghai, Shanghai Municipality, China
  • Shanghai Liquan Hospital Shanghai, Shanghai Municipality, China
  • The General Hospital of Western Theater Command PLA Chengdu, Sichuan, China
View Trial Details
Recruiting

A Multicenter, Open-Label, Non-Randomized, Single-Arm Clinical Study of Nanobody CD5-CAR T Cell Therapy for Refractory/Relapsed T Lymphocyte Malignancies

NCT07070323

Conditions
Acute Lymphoblastic Leukemia, in Relapse, Hematologic Diseases, Hemic and Lymphatic Diseases, +13 more
Locations
  • Beijing GoBroad Hospital Beijing, Beijing Municipality, China
  • Zhaxin Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai Shanghai, Shanghai Municipality, China
  • Shanghai Liquan Hospital Shanghai, Shanghai Municipality, China
  • The General Hospital of Western Theater Command PLA Chengdu, Sichuan, China
View Trial Details
Recruiting

A Study of pCAR-19B in the Treatment of CD19-positive Relapsed/Refractory B-ALL in Children and Adolescents

NCT05334823

Conditions
Acute Lymphoblastic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +11 more
Locations
  • Beijing Children's Hospital.Capital Medical University Beijing, Beijing Municipality, China
  • Beijing GoBroad Boren Hospital Beijing, Beijing Municipality, China
  • Pediatric Hematology department of Tongji Hospital affiliated to Tongji Medical College of Huazhong University of Science and Technology Wuhan, Hubei, China
  • Tongji Hospital affiliated to Tongji Medical College of Huazhong University of Science and Technology Wuhan, Hubei, China
View Trial Details
Active, not recruiting

A Study of Revumenib in Combination With Chemotherapy for Patients Diagnosed With Relapsed or Refractory Leukemia

NCT05761171

Conditions
Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +21 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • Arkansas Children's Hospital Little Rock, Arkansas, United States
  • Kaiser Permanente Downey Medical Center Downey, California, United States
  • Loma Linda University Medical Center Loma Linda, California, United States
View all 84 locations
View Trial Details
Active, not recruiting

Blinatumomab and Combination Chemotherapy or Dasatinib, Prednisone, and Blinatumomab in Treating Older Patients With Acute Lymphoblastic Leukemia

NCT02143414

Conditions
Acute Lymphoblastic Leukemia, B Acute Lymphoblastic Leukemia, B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1, +23 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Banner University Medical Center - Tucson Tucson, Arizona, United States
  • University of Arizona Cancer Center-North Campus Tucson, Arizona, United States
  • John L McClellan Memorial Veterans Hospital Little Rock, Arkansas, United States
View all 195 locations
View Trial Details

Related conditions